Clinical Trials Logo
  1. Home
  2. Nasolabial Folds
  3. NCT06018987

A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds

Nasolabial Folds Clinical Trial

Official title:
A Multicenter, Evaluator-blinded, Randomized, Delayed Treatment Control Group Study of the Safety and Effectiveness of HAC 20L for the Correction of Moderate to Severe Nasolabial Folds

Clinical Trial Summary

Nasolabial folds (NLF) are the two skin folds that run from each side of the nose to the corners of the mouth. Prominent NLFs distort the contour of the midface, giving a fatigued and aged appearance. Soft tissue fillers can be used to reduce the depth of NLFs and restore a more youthful appearance. The purpose of this study is to evaluate how safe and effective HAC 20L is in the correction of moderate to severe NLF in adult participants. HAC 20L is an investigational drug being developed for the treatment of NLF. There are 2 cohorts in this study. In each cohort participants are assigned to either the treatment group or no-treatment control group. There is a 1 in 3 chance that participants will be assigned to the no-treatment control group. Around 255 adult participants with moderate to severe NLF will be enrolled in the study at approximately 20 sites worldwide. Participants in the treatment group will receive an injection of HAC 20L to the NLF on Day 1 in Cohort 1 and Cohort 2 with the option of re-treatment after completion of Month 12 visit. The control group will receive no treatment but will be offered an optional HAC 20L treatment after 6 months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be examined by completing effectiveness questionnaires by the subjects, evaluating investigator (EI) and central reviewers as well as monitoring safety assessments such as vital signs, blood tests, injection site responses and adverse events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06018987
Study type Interventional
Source AbbVie
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date September 5, 2023
Completion date August 19, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT01115634 - Autologous Fibroblast Transplantation in Facial Deformities Phase 2
Completed NCT01012661 - Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler Phase 4
Completed NCT00778531 - Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds Phase 4
Completed NCT03932045 - A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds N/A
Completed NCT02647853 - Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers Phase 1
Completed NCT01069354 - Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds N/A
Completed NCT00797459 - Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds N/A
Completed NCT00850889 - Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds Phase 4
Recruiting NCT06093321 - A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement N/A
Not yet recruiting NCT06295172 - A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement N/A
Completed NCT01060943 - An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds Phase 3
Completed NCT05612958 - Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds N/A
Completed NCT02672644 - Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep Phase 4
Completed NCT01012388 - Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color Phase 4
Completed NCT01635855 - Belotero Post Approval Study Phase 4
Completed NCT02179736 - A Post Market Evaluation After Treatment of Nasolabial Folds N/A
Terminated NCT00716443 - Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections Phase 4
Recruiting NCT02607670 - Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds Phase 2
Completed NCT00823069 - Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose N/A
Recruiting NCT06367634 - TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults N/A